Cancer Sugar Shield Helps Tumours Evade Immunity

Original Article by Kevin Naidoo | The Conversation | 21 August 2026

Cancer sugar shield research from UCT reveals how tumours evade immunity and could support new vaccines, biomarkers and precision therapies.

Image | Alioui Mohammed Elamine | iStock-2229394760

Cancer sugar shield research from UCT reveals how tumours evade immunity and could support new vaccines, biomarkers and precision therapies.

Subscription Required

You must be a subscriber to access all of this content.

Already a subscriber? Log in here

Dr Thembisile Xulu is the new health Director-General, inheriting a strained department, healthcare-worker shortages and NHI litigation.

Gauteng is losing 100 nurses a month and needs R5.7bn to fill a 16,000-post gap. This shortage now flagged as a key risk to the NHI rollout.

Regulation, not demand, blocks affordable cover: medical schemes should be allowed to offer low-cost benefit options (LCBOs) now.